These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 22345666)

  • 21. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).
    van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR
    Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus.
    Leffler J; Gullstrand B; Jönsen A; Nilsson JÅ; Martin M; Blom AM; Bengtsson AA
    Arthritis Res Ther; 2013 Aug; 15(4):R84. PubMed ID: 23945056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
    Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
    J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome.
    Leffler J; Stojanovich L; Shoenfeld Y; Bogdanovic G; Hesselstrand R; Blom AM
    Clin Exp Rheumatol; 2014; 32(1):66-70. PubMed ID: 24295292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced anti-TNFalpha autoantibody levels coincide with flare in systemic lupus erythematosus.
    Sjöwall C; Ernerudh J; Bengtsson AA; Sturfelt G; Skogh T
    J Autoimmun; 2004 Jun; 22(4):315-23. PubMed ID: 15120755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S; Trendelenburg M
    J Leukoc Biol; 2017 Feb; 101(2):481-491. PubMed ID: 27630215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil extracellular traps (NETs) - formation and implications.
    Zawrotniak M; Rapala-Kozik M
    Acta Biochim Pol; 2013; 60(3):277-84. PubMed ID: 23819131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus.
    Al-Mayouf SM; Abanomi H; Eldali A
    Int J Rheum Dis; 2011 Feb; 14(1):81-5. PubMed ID: 21303486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG; Mangueira CL; Cruz LA; Cruz CM
    Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary C1q deficiency and systemic lupus erythematosus.
    Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
    QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement and systemic lupus erythematosus.
    Walport MJ
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S279-93. PubMed ID: 12110148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.